Unión Europea - español - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmológicos - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Venezuela - español - Instituto Nacional de Higiene

byo latin america, c.a. - ciprofloxacina - solucion - 0,3 %

Venezuela - español - Instituto Nacional de Higiene

byo latin america, c.a. - ciprofloxacina - fluocinolona acetonido - solucion - 0,3 % - 0,025 %

Venezuela - español - Instituto Nacional de Higiene

byo latin america, c.a. - dorzolamida -timolol - soluci - 2,0 %-0,5 %

Venezuela - español - Instituto Nacional de Higiene

byo latin america, c.a. - lansoprazol - comprimidos bucodispersables - 15 mg

Venezuela - español - Instituto Nacional de Higiene

byo latin america, c.a. - lansoprazol - comprimidos bucodispersables - 30 mg

Venezuela - español - Instituto Nacional de Higiene

byo latin america, c.a. - levosulpiride - comprimidos - 25 mg

Venezuela - español - Instituto Nacional de Higiene

byo latin america, c.a. - oxicodona - comprimido de liberaci - 10 mg(a)

Venezuela - español - Instituto Nacional de Higiene

byo latin america, c.a. - oxicodona - comprimido de liberaci - 20 mg (a)

Venezuela - español - Instituto Nacional de Higiene

byo latin america, c.a. - oxicodona - comprimido de liberaci - 40 mg (a)